-
Please visit my new blog at fluidicmems.com for microfluidics/bioMEMS content.
Lily on Twitter (@lilyykim)
- Thread-based microfluidics makes it onto the @MakeMagazine blog: http://bit.ly/9Ao96p 7 hours ago
Tags
-
Biopharma and healthcare
Innovation
Microfluidics / BioMEMS / Lab-on-a-chip
Nanotechnology and Medicine
Archives
- February 2010 (1)
- January 2010 (7)
- December 2009 (6)
- November 2009 (5)
- October 2009 (4)
- September 2009 (5)
- August 2009 (2)
- July 2009 (6)
- June 2009 (6)
- May 2009 (7)
- April 2009 (3)
Monthly Archives: July 2009
Microfluidics and the hunt for the killer app
In microfluidics, the search for a killer app has been on since the early 90s. Although some microfluidic products have successfully appeared on the market (e.g. inkjet printheads), microfluidics hasn’t taken the world by storm as fast as people thought it might. Over the years, leaders in the field have speculated about a potential killer [...]
Sangeeta Bhatia and micro-liver chips on NOVA
Last week Professor Sangeeta Bhatia was featured in a fantastic profile on NOVA’s scienceNOW. Bhatia is recognized as a pioneer in bioMEMS and directs the Laboratory for Multiscale Regenerative Technologies at MIT. Although Bhatia’s work explores a wide range of topics, she is most well-known for her development of micro-livers-on-a-chip. Primary liver cells are notoriously [...]
MIT OpenCourseWare on BioMEMS
Several years back, MIT decided to make its course materials freely available on the web. Not all materials from all courses are available, but there are several offerings in microsystems/microfluidics/BioMEMS if you’d like to construct a do-it-yourself education. For example:
HST.410J / 6.07J Projects in Microscale Engineering for the Life Sciences
6.777J / 2.372J Design and Fabrication [...]
How commercializable is microfluidics research?
In grad school I often secretly wondered about the commercial potential of our microfluidics research. I’ve touched on this issue before, and Derek Lowe recently discussed what makes a technology useful in lab (many microfluidic devices are platform technologies designed for use in lab). In the June 21st issue of Lab on a Chip, Holger [...]
Risk-taking in pharma vs. venture capital
I’ve been thinking lately about risk-taking in scientific research, focusing on academia. Yesterday Seth Godin wrote about the nonlinear relationship between risk and reward: small increases in risk can yield large rewards, but only large risks yield the largest rewards.
This got me wondering about where pharma is on the risk-taking spectrum, and whether pharma should [...]
My entry to the Exquisite Corpse of Science